Literature DB >> 4067288

Binding to and antibacterial effect of aztreonam, temocillin, gentamicin and tobramycin on human faeces.

M P Hazenberg, A M Pennock-Schröder, J P van de Merwe.   

Abstract

Aztreonam, temocillin, gentamicin and tobramycin were studied for their effect on the human faecal flora in vitro and for their usefulness for selective decontamination (SD) of the gastrointestinal tract. The sensitivities of the obligately anaerobic flora and the Gram-negative facultatively anaerobic bacteria were determined and the ratio was expressed as SD factor. The high SD factor of the flora from most subjects for aztreonam and tobramycin indicates that the drugs are useful for SD in contrast to temocillin and gentamicin. Binding to and subsequent release of tobramycin from faeces are presumed to facilitate the maintenance of adequate concentrations in the intestine despite the discontinuous intake.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4067288      PMCID: PMC2129534          DOI: 10.1017/s0022172400062689

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  17 in total

1.  Simplified, accurate method for antibiotic assay of clinical specimens.

Authors:  J V Bennett; J L Brodie; E J Benner; W M Kirby
Journal:  Appl Microbiol       Date:  1966-03

2.  Oral bioavailability of the monobactam aztreonam (SQ 26,776) in healthy subjects.

Authors:  E A Swabb; A A Sugerman; M Stern
Journal:  Antimicrob Agents Chemother       Date:  1983-04       Impact factor: 5.191

3.  Antimicrobial prophylaxis against infection in neutropenic patients.

Authors:  L S Young
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

4.  Effects of the human intestinal flora on germ-free mice.

Authors:  M P Hazenberg; M Bakker; A Verschoor-Burggraaf
Journal:  J Appl Bacteriol       Date:  1981-02

5.  Binding of aminoglycosides to feces.

Authors:  G H Wagman; J V Bailey; M J Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1974-10       Impact factor: 5.191

6.  BRL 17421, a novel beta-lactam antibiotic, highly resistant to beta-lactamases, giving high and prolonged serum levels in humans.

Authors:  B Slocombe; M J Basker; P H Bentley; J P Clayton; M Cole; K R Comber; R A Dixon; R A Edmondson; D Jackson; D J Merrikin; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1981-07       Impact factor: 5.191

7.  Selective antimicrobial modulation of the intestinal flora of patients with acute nonlymphocytic leukemia: a double-blind, placebo-controlled study.

Authors:  H F Guiot; P J van den Broek; J W van der Meer; R van Furth
Journal:  J Infect Dis       Date:  1983-04       Impact factor: 5.226

8.  Selective antimicrobial modulation of human microbial flora: infection prevention in patients with decreased host defense mechanisms by selective elimination of potentially pathogenic bacteria.

Authors:  H F Guiot; J W van der Meer; R van Furth
Journal:  J Infect Dis       Date:  1981-05       Impact factor: 5.226

9.  The screening of four aminoglycosides in the selective decontamination of the digestive tract in mice.

Authors:  D van der Waaij; J Aberson; H A Thijm; G W Welling
Journal:  Infection       Date:  1982-01       Impact factor: 3.553

10.  Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients.

Authors:  H G de Vries-Hospers; D T Sleijfer; N H Mulder; D van der Waaij; H O Neiweg; H K van Saene
Journal:  Antimicrob Agents Chemother       Date:  1981-05       Impact factor: 5.191

View more
  2 in total

1.  The non-enzymatic inactivation of thirteen beta-lactam antibiotics in human faeces.

Authors:  G Jansen; F Weissing; H de Vries-Hospers; R Tonk; D van der Waaij
Journal:  Infection       Date:  1992 Nov-Dec       Impact factor: 3.553

2.  Norfloxacin binds to human fecal material.

Authors:  C Edlund; L Lindqvist; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.